BRPI0513991A - composição para a promoção de relaxamento de músculo liso vascular - Google Patents

composição para a promoção de relaxamento de músculo liso vascular

Info

Publication number
BRPI0513991A
BRPI0513991A BRPI0513991-0A BRPI0513991A BRPI0513991A BR PI0513991 A BRPI0513991 A BR PI0513991A BR PI0513991 A BRPI0513991 A BR PI0513991A BR PI0513991 A BRPI0513991 A BR PI0513991A
Authority
BR
Brazil
Prior art keywords
composition
vasodilator
active ingredient
volatile
saturated
Prior art date
Application number
BRPI0513991-0A
Other languages
English (en)
Inventor
Adrian Francis Davis
Original Assignee
Futura Medical Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Futura Medical Dev Ltd filed Critical Futura Medical Dev Ltd
Publication of BRPI0513991A publication Critical patent/BRPI0513991A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSIçãO PARA A PROMOçãO DE RELAXAMENTO DE MúSCULO LISO VASCULAR Uma composição para aplicação tópica a uma parte do corpo compreende um vasodilatador, por exemplo, trinitrato de gliceril, como ingrediente ativo dissolvido em uma mistura de solventes voláteis e não voláteis de diferentes capacidades de formação de solvato para o vasodilatador. O vasodilatador está presente na composição em uma concentração saturada ou levemente abaixo da saturação, pela qual a evaporação do solvente volátil em uso manterá o vasodilatador em concentrações saturadas ou supersaturadas no resíduo, assim o vasodilatador permanecerá saturado ou supersaturadono solvente restante e, uma vez que o ingrediente ativo passa através da pele e é absorvido na corrente sangüínea e assim torna-se esgotado na composição residual, a evaporação continuada do solvente volátil manterá o ingrediente ativo em um nível de saturação ou supersaturação na composição residual por toda a parte principal da fase de absorção, dessa forma maximizando os níveis de absorção porém em um nível de dosagem moderado.
BRPI0513991-0A 2004-08-09 2005-08-08 composição para a promoção de relaxamento de músculo liso vascular BRPI0513991A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0417675.6A GB0417675D0 (en) 2004-08-09 2004-08-09 Composition for promoting vascular smooth muscle relaxation
PCT/GB2005/003110 WO2006016139A1 (en) 2004-08-09 2005-08-08 Composition for promoting vascular smooth muscle relaxation

Publications (1)

Publication Number Publication Date
BRPI0513991A true BRPI0513991A (pt) 2008-05-20

Family

ID=32982731

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513991-0A BRPI0513991A (pt) 2004-08-09 2005-08-08 composição para a promoção de relaxamento de músculo liso vascular

Country Status (20)

Country Link
US (1) US8951553B2 (pt)
EP (1) EP1786468B1 (pt)
JP (1) JP2008509208A (pt)
KR (1) KR101204397B1 (pt)
CN (1) CN101022832A (pt)
AT (1) ATE433761T1 (pt)
AU (1) AU2005271049B2 (pt)
BR (1) BRPI0513991A (pt)
CA (1) CA2573386C (pt)
DE (1) DE602005014999D1 (pt)
ES (1) ES2328380T3 (pt)
GB (1) GB0417675D0 (pt)
IL (1) IL180577A0 (pt)
MX (1) MX2007001639A (pt)
NO (1) NO20070874L (pt)
NZ (1) NZ552789A (pt)
RU (1) RU2407519C2 (pt)
TW (1) TWI371273B (pt)
WO (1) WO2006016139A1 (pt)
ZA (1) ZA200700193B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0602224D0 (en) * 2006-02-03 2006-03-15 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
GB201713160D0 (en) * 2017-08-16 2017-09-27 Futura Medical Dev Ltd Topical composition
CN109276565A (zh) * 2018-10-19 2019-01-29 太阳雨林(厦门)生物医药有限公司 硝化甘油在制备治疗慢性肢体缺血性疾病药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704119A (en) * 1983-02-03 1987-11-03 Alza Corporation Method comprising transdermal and buccal treatment of angina
HU199678B (en) * 1988-07-08 1990-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producing aerosols containing nitroglicerol
US5370862A (en) * 1990-06-13 1994-12-06 Schwarz Pharma Ag Pharmaceutical hydrophilic spray containing nitroglycerin for treating angina
DE4018919C2 (de) 1990-06-13 1994-08-25 Sanol Arznei Schwarz Gmbh Nitroglycerin-Spray
DE4026072A1 (de) 1990-08-17 1992-02-20 Sanol Arznei Schwarz Gmbh Nitroglycerinhaltiger, hydrophiler, waessriger pumpspray
WO1994002119A1 (en) 1992-07-23 1994-02-03 Hisamitsu Pharmaceutical Co., Inc. Percutaneously administrable base composition and drug composition prepared therefrom
US5807569A (en) * 1993-05-27 1998-09-15 Smithkline Beecham P.L.C. Topical composition
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
GB9802078D0 (en) * 1998-01-30 1998-03-25 Futura Medical Limited Preparation for treatment of erectile dysfunction

Also Published As

Publication number Publication date
EP1786468B1 (en) 2009-06-17
NO20070874L (no) 2007-02-15
ES2328380T3 (es) 2009-11-12
IL180577A0 (en) 2007-06-03
CA2573386A1 (en) 2006-02-16
AU2005271049A1 (en) 2006-02-16
KR101204397B1 (ko) 2012-11-26
US20080081058A1 (en) 2008-04-03
TWI371273B (en) 2012-09-01
CN101022832A (zh) 2007-08-22
RU2407519C2 (ru) 2010-12-27
DE602005014999D1 (de) 2009-07-30
WO2006016139A1 (en) 2006-02-16
TW200605874A (en) 2006-02-16
CA2573386C (en) 2013-10-01
ZA200700193B (en) 2009-03-25
ATE433761T1 (de) 2009-07-15
EP1786468A1 (en) 2007-05-23
KR20070054631A (ko) 2007-05-29
AU2005271049B2 (en) 2011-08-04
US8951553B2 (en) 2015-02-10
JP2008509208A (ja) 2008-03-27
MX2007001639A (es) 2007-04-24
NZ552789A (en) 2010-12-24
RU2007106941A (ru) 2008-09-20
GB0417675D0 (en) 2004-09-08

Similar Documents

Publication Publication Date Title
ES2302350T3 (es) Combinacion sinergica de inhibidores de pde y agonistas de adenilatociclasa o agonistas de guanililciclasa.
WO2008108286A1 (ja) 経皮吸収医薬組成物、医薬組成物貯蔵ユニットおよびこれを利用する経皮吸収製剤
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
PE20070074A1 (es) Formulaciones de diclofenaco
PE20081114A1 (es) Composiciones farmaceuticas bioadhesivas de agente dual para uso topico
BRPI0513991A (pt) composição para a promoção de relaxamento de músculo liso vascular
AR039388A1 (es) Formulaciones liquidas de baja dosis de entecavir y uso
BR0107062A (pt) Processo e dispositivo para o enriquecimento e estabilização de estrogênios conjugados de urina de égua
AR054736A1 (es) Composicion para promover la relajacion del musculo liso vascular
ES2724173T3 (es) Composición farmacéutica
BRPI0509585A (pt) preparação farmacêutica para a aplicação na pele com um teor de drospirenona
TH94304A (th) องค์ประกอบสำหรับช่วยคลายกล้ามเนื้อเรียบของหลอดเลือด
US9265721B2 (en) Composition for promoting vascular smooth muscle relaxation
KR900017588A (ko) 상승효과를 나타내는 배합물 및 이의 치료제로서의 용도
TH94304B (th) องค์ประกอบสำหรับช่วยคลายกล้ามเนื้อเรียบของหลอดเลือด
Said Pulmonary Responses to Inhaled Particles: Role of Vasoactive Substances
JPH11255659A (ja) ふくらはぎ及び足首捲着用シート
CN105687198A (zh) 一种吴茱萸碱透皮吸收喷雾剂
EA012648B1 (ru) Фармацевтическая композиция для чрескожной доставки активного агента (варианты)
TH69756A (th) สูตรผสมที่ใช้ภายนอกที่มีความเสถียรซึ่งประกอบด้วยเคโตโพรเฟน
RU2004104399A (ru) Композиция для обработки растений

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.